 

\ ”\w

/ C45 — c7 ,_3

 

—___.—

PATIENT HISTORY:
CHIEF COMPLAINT] PRE—OP/ POSTOP D
LMP DATE: Not provided.

PROCEDURE: Exploratory Iaparoscopy. total abdominal hysterectomy.

lymph node dissection.

 

CW.W WWW-“[4 N“ gaff/3

Sza: Wm cm ,0

IAGNOSIS: Endometrial cancer.

SPECIFIC CLINICAL QUESTION: Not provided.
OUTSIDE TISSUE DIAGNOSIS: Not provided,

PRIOR MALIGNANCY: Not provided.

CHEMORADIATION THERAPY: Not provided.

OTHER DISEASES: Not provided.
ADDENDA:
Addendum
Antibody/Antigen
ER (blocks 1A and 10)
PR (block 1A)

(block 10)

.h»67 (blocks 1A and 10)
P53 (blocks :LA and 10)

Expression in 97%
Patchy strong stai

Result
Diffuse intermediate expression
Diffuse moderate to
Negative component: within a moderate to strong intensely staining

J/JJ/ll

bilateral salplngo-oophoreotomy. pelvic and periaortic

Comm Date: 1

strong expression

of the tumor cells
ning and intermediate staining.

Utilizing formalin—fixed (8-96 hour range), paraffin embedded tissue, immunohietology is
performed with the following selected antibodies and designated antibody clone (5) , directed
against the following antigenic target“) , with adequate positive and negative internal and

external controls. Antibodies are optimi

ANTIBODY CLONE
ER SP1
PR 122
Ki - 67 3 o — 9
P53 130— '7
Commmr.

 

FINAL DIAGNOSIS:

PART 1: UTERUS WITH BILATERAL ADN
SALPINGO-OOPHORECTOMY —
A.

INVOLVING APPROXIMATELY 50% or EN

TARGET ANTIGEN

Estrogen Receptor
Progesterone receptor
Proliferation Marker
Serouo Carcinoma

EXA (334 GRAMS), TOTAL ABDOMINAL HYSTERECTOMY AND BILATERAL
HIGH-GRADEPOORLY DIFFERENTIATED ADENOCARCINOMACARCINOMA OF ENDOMETRIUM,

OF MYOMETRIUM (GRADE 3. STAGE 1A).

ENDOMEI’RIAL POLYP.
ADENOMYOSIS.

31!“? .0.”

HYPERPLASIA.

FOCAL LYMPHOVASCULAR INVASION IDENTIFIED.
BACKGROUND ENDOMETRIUM SHOWS SI
DISORDERED PROUFERATIVE PATTERN.

MPLE AND COMPLEX ATYPICAL HYPERPLASIA AND

CHRONIC CERVICITIS, SQUAMOUS MET APLASIA. REACTIVE CHANGES AND MICROGLANDULAR

G. BILATERAL OVARIES AND FALLOPIAN TUBES, NEGATIVE FOR TUMOR.

PART 2: RIGHT PELVIC LYMPH NODES. DISSECTION -
TEN LYMPH NODES NEGATIVE FOR TUMOR (0110).

PART 3: RIGHT COMMON AND PERIAORTIC LYMPH NOD

TWO LYMPH NODES NEGATIVE
PART 4: LEFT PELWC LYMPH NODES, DI

FOR TUMOR (N2).
SSECTION -

ONE LYMPH NODE NEGATIVE FOR TUMOR (011).

PART 5: LEFT PELVIC LYMPH MODES, DISSECTION -
TWELVE LYMPH NODES NEGATIVE FOR TUMOR (II/12).

PART 6: LEFT COMMON AND PERIARO'ITC LYMPH NODE

SEVEN LYMPH Nooss NEGATIVE FOR TUMOR (am.
h:

an.

E8. DISSECTION —

UUID : 32837D2C-0DZB-4A47-9E42-1A805CB4A25A

TCGA-BG-A222-e1A-PR Rlellcllﬁllcilfed

IllIIHllllllllllllllllllllllll
IIIIIIIIIIII'IIIIIIIIIIfIIIIIIIIIIIIII||||llllllllllllllllllllllll

8. DISSECTION -

 
    
  
  

Die nosis Dimepcncy
Primary Tumol Site Discrepancy
\

MAMA Discus-lacy

Prior Malilninry Nisloly

Qual/Synchlonau: Frinury Nomi
(Lei: (than);

 

‘
4.. —

 

 

COMMENT:
Pelvic cytology (w negative for malignant cells.

Although tumor grossly appears to Involve 90% of ondomotrlal surface. microscopically approximately half of the
submitted section: shows adenocarcinoma and the remaining half shows simple and complex atypical hyperplaala and
dlsoredered proliferatlve endometrium.

Immunosulns to further characterize the nature of this tuner (endometriold versus serous) are requested and the results

wlll be reported in an addendum.
Wont or pelvic lymph nodes will be reviewed by the M

_ - .._—._...-———-——«—... ... . ....._..

 

CASE SYNOPSIS:
SYNOPTIC - PRIMARY UTERINE ENDOMETRIAL CARCINOMA a. CARCINOSARCOMA : HYSTERECTOMY
SPECIMENS
TUMOR TYPE: Endometroid admrdnoma, NOS

HISTOLOGIC GRADE (epithelial neoplasm ieoiiiﬁliiicraichmi‘r‘ﬂﬁa nuclear]:
Poorly differentiated (FIGO 3)

ARCHITECTURAL GRADE: Poorly differentiated
NUCLEAR GRADE: Grade 3
TUMOR SIZE: Maximum dimension: 70 mm

PERCENT OF ENDOMETRIAL SURFACE lNVOLVEMENT: .
Anterior endomyometrium: 50 %. Posterior endomyomelriwn: 50 “lo

DEPTH OF INVASION: Less than 1/2 thickness of myomdrlum
ANGIOLYMPHATIC INVASION: Yes
LYMPH NODES POSITIVE: Number of lymph nodes positive:: 0
LYMPH MODES EXAMINED: Total number of lymph nodes examined: 32
T STAGE, PATHOLOGIC: pT1 a
N STAGE, PATHOLOGIC: pNO
M STAGE. PATHOLOGIC: Not applicable

IA

FIGO STAGE:

mam... -, . ,...

 

